| Document Date: 2013-07-12 14:26:15
Open Document File Size: 1,13 MBShare Result on Facebook
Company Hoffmann-La Roche Limited / Genentech Inc. / Health Canada Hoffmann-La Roche Limited / FOREWORD Health Canada / / Country Canada / / Event Product Issues / FDA Phase / / IndustryTerm cell bank / pharmaceutical development / bevacizumab manufacturing process / drug product / manufacturing steps / conventional pharmaceutical equipment / manufacturing equipment / cancer treatment / cell banks / mL sterile solution / particular product / sterile liquid solution / cell bank system / mg/mL solution / manufacturing process consistency / food / manufacturing process / butyl rubber stopper / / MedicalCondition hypertension / cancer / arterial thromboembolism / sterility / tumour metastasis / metastatic carcinoma / nausea / tumour / metastatic disease / diarrhea / tumours / / MedicalTreatment radiation therapy / chemotherapy / Intravenous infusion / / OperatingSystem OSE / / Organization Health Products and Food Branch / Biologics and Genetic Therapies Directorate / / Product mL / AVASTIN / fluorouracil / Bevacizumab / wound healing / SBD / / PublishedMedium the Health Canada review / / Technology Pharmacokinetics / radiation / chemotherapy / Pharmacodynamics / recombinant DNA technology / /
SocialTag |
sbd_smd_2006_avastin_089366_e.doc